FIELD: medicine.
SUBSTANCE: invention refers to medicine and represents degradable removed pharmaceutical implant for continuous release of one or more therapeutic agents in individual. Implant consists of tube containing external biodegradable wall surrounding cavity, where outer wall has multiple holes, and cavity contains one or several sets of microparticles. Microparticles contain HIV Inhibitor, and at least of 85 % wt/wt% microparticles can not pass through holes with diameter of 1-100 mqm through outer wall.
EFFECT: invention implementation allows to deliver one or more active ingredients for long time.
14 cl, 5 dwg, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS CONTAINING CLONIDINE, APPLICABLE FOR TREATING POSTOPERATIVE PAIN | 2009 |
|
RU2510263C2 |
| IMPLANTED DEVICES FOR TREATING HIV | 2009 |
|
RU2546529C2 |
| EMULSION FOR MICROENCAPSULATION CONTAINING BIODEGRADABLE SURFACTANT BLOCK COPOLYMERS AS STABILIZERS | 2011 |
|
RU2617057C2 |
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| COMPOUNDS CONTAINING CLONIDINE IN DEGRADABLE POLYMER | 2009 |
|
RU2494731C2 |
| PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE | 2017 |
|
RU2756514C1 |
| HIGH STABILITY PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2427383C2 |
| BIODEGRADABLE, SEMI-CRYSTALLINE, PHASE SEPARATED, THERMOPLASTIC MULTI-BLOCK COPOLYMERS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2012 |
|
RU2662818C2 |
| TETRACYCLINE COMPLEXES WITH SUSTAINABLE ACTIVITY | 2019 |
|
RU2806036C2 |
| COMPOSITIONS AND METHODS FOR LONG-TERM RELEASE OF ANTAGONISTS OF GONADOTROPIN-RELEASING HORMONE (GnRH) | 2018 |
|
RU2789057C2 |
